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Key points 
 
• The shape of the cardiac atrial action potential is influenced by the flow of a transient 
 outward K+ current (ITO) across atrial muscle cell membranes. 
• Whether changes in ITO could alter atrial cell action potentials in ways that could 
 affect mechanisms of abnormal heart rhythms (arrhythmias) is unclear, because 
 currently available ITO blocking drugs are non-selective. 
• We used the “dynamic-clamp” technique, for the first time in atrial cells isolated 
 from patients, and from rabbits, to electrically simulate selective changes in ITO 
 during action potential recording. 
• We found that ITO decrease prolonged atrial cell action potential duration and, under 
 β-adrenergic-stimulation, provoked abnormal membrane potential oscillations 
 (afterdepolarisations) that were preventable by ITO increase or a β-blocker. 
• These results help us better understand the contribution of ITO to atrial cell action 
 potential shape and mechanisms of arrhythmia, with potential implications for both 
 the development and treatment of atrial fibrillation. 
 
Word count: 146 
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Abstract 
 
Background & aim. Human atrial transient outward K+ current (ITO) is decreased in a 
variety of cardiac pathologies, but how ITO reduction alters action potentials (AP) and 
arrhythmia mechanisms is poorly understood, owing to non-selectivity of ITO blockers. 
Aim: to investigate effects of selective ITO changes on AP shape and duration (APD), 
and on afterdepolarisations or abnormal automaticity with β-adrenergic-stimulation, 
using the dynamic-clamp technique in atrial cells. Methods & Results. Human and 
rabbit atrial cells were isolated by enzymatic dissociation, and electrical activity 
recorded by whole-cell-patch clamp (35-37oC). Dynamic-clamp-simulated ITO reduction 
or block slowed AP phase 1 and elevated the plateau, significantly prolonging APD, in 
both species. In human atrial cells, ITO block (100% ITO subtraction) increased APD50 by 
31%, APD90 by 17%, and APD-61mV (reflecting cellular effective refractory period) by 
22% (P<0.05 for each). Interrupting ITO block at various time points during 
repolarisation revealed that the APD90 increase resulted mainly from plateau-elevation, 
rather than from phase 1-slowing or any residual ITO. In rabbit atrial cells, partial ITO 
block (~40% ITO subtraction) reversibly increased the incidence of cellular arrhythmic 
depolarisations (CADs; afterdepolarisations and/or abnormal automaticity) in the 
presence of the β-agonist isoproterenol (0.1 µM; ISO), from 0% to 64% (P<0.05). ISO-
induced CADs were significantly suppressed by dynamic-clamp increase in ITO (~40% 
ITO addition). ISO+ITO decrease-induced CADs were abolished by β1-antagonism with 
atenolol at therapeutic concentration (1 µM). Conclusion. Atrial cell action potential 
changes from selective ITO modulation, shown for the first time using dynamic-clamp, 
have the potential to influence reentrant and non-reentrant arrhythmia mechanisms, with 
implications for both the development and treatment of atrial fibrillation. 
 
 
Abbreviations 
θ, conduction velocity; λ, reentry wavelength; 4-AP, 4-aminopyridine; AF, atrial 
fibrillation; APD, action potential duration; APDx, action potential duration at x% 
repolarisation; BCL, basic cycle length; CAD, cellular arrhythmic depolarisation; CHF, 
congestive heart failure; CICR, Ca2+-induced Ca2+ release; CRN, Courtemanche, 
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Ramirez, Nattel mathematical model; DAD, delayed afterdepolarisation; EAD, early 
afterdepolarisation; ERP, effective refractory period; h
∞
, steady-state inactivation 
parameter; ICaL, L-type Ca2+ current; IK1, inward rectifier K+ current; IKACh, 
acetylcholine-activated K+ current; IKur, ultra-rapid delayed rectifier K+ current; INa/Ca, 
Na+/Ca2+ exchanger current; ISO, isoproterenol; ITO, transient outward K+ current; ITO 
Gmax, peak ITO conductance; LVSD, left ventricular systolic dysfunction; m∞, steady-
state activation parameter; V0.5, voltage of half activation or inactivation; Vm, membrane 
voltage; Vmax, action potential maximum upstroke velocity; τh, inactivation time 
constant; τm, activation time constant. 
 
 
Introduction 
 The cardiac transient outward K+ current (ITO) activates rapidly upon action 
potential (AP) initiation. Its large magnitude in atrial cells of many species, including 
human, and in ventricular cells of some rodents contributes to the characteristic spiky 
AP shape in these cells; with fast early repolarisation (phase 1) and small plateau 
(Workman et al. 2001; Xu et al. 1999; Workman et al. 2000; Sah et al. 2002; Madhvani 
et al. 2011). In such cells, ITO reduction can markedly alter AP shape. For example, in 
atrial (Xu et al. 1999) and ventricular (Sah et al. 2002) cells from mice genetically 
engineered for reduced ITO, the plateau was elevated and AP duration at late (90%) 
repolarisation (APD90) markedly prolonged. ITO reduction has the potential, therefore, to 
influence various electrophysiological mechanisms of cardiac arrhythmias. Plateau-
elevation may cause afterdepolarisations or abnormal automaticity, particularly during 
adrenergic-elevation (Workman, 2010), and APD90 increase may inhibit reentry 
(Workman et al. 2011). 
 Atrial fibrillation (AF) is the most common cardiac arrhythmia, and atrial ITO is 
markedly reduced in chronic AF and in several predisposing pathologies, by 
electrophysiological remodelling (Le Grand et al. 1994; Van Wagoner et al. 1997; 
Christ et al. 2008; Workman et al. 2009; Nattel et al. 2007; Workman et al. 2008; 
Schotten et al. 2011; Dobrev et al. 2012). Furthermore, some drugs used in the 
treatment of AF also inhibit ITO (Wang et al. 1995; Varro A et al. 1996; Gross & Castle 
1998; Marshall et al. 2012). The rapid activation of this current means that its reduction, 
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by affecting membrane voltage (Vm) early during repolarisation, has knock-on 
(secondary) effects on other voltage-gated currents, e.g. L-type Ca2+ current (ICaL) and 
resultant Ca2+-induced Ca2+ release (CICR) and Na+/Ca2+-exchanger current (INa/Ca) 
(Sah et al. 2003) with inevitable complex, species- and pathology-dependent influences 
on the plateau and APD90. 
 However, it is unclear what effect ITO reduction has on atrial APs in humans and 
most other mammals, because of the non-specificity of the best available ITO blocker, 4-
aminopyridine (4-AP). This drug additionally blocks ultra-rapid delayed rectifier K+ 
current (IKur) (Wang et al. 1993) and, although atrial IKur may be small in some species, 
e.g. rabbit (Giles & Imaizumi 1988; Lindblad et al. 1996), its large magnitude in human 
atrium (Wang et al. 1993; Van Wagoner et al. 1997; Christ et al. 2008) necessitates the 
use of other tools for studying effects of ITO reduction. Mathematical modelling is a 
powerful alternative, but yielded variable results depending on the algorithm used and 
intrinsic AP shape, and on constraining electrophysiological parameters (Nygren et al. 
1998; Courtemanche et al. 1998; Zhang et al. 2005; Grandi et al. 2011; Marshall et al. 
2012). Moreover, such models can only incorporate known experimental data. The 
dynamic-clamp technique (Wilders, 2006), however, provides the opportunity to reduce 
ITO selectively in live atrial cells. A voltage- and time-dependent current based on a 
mathematical model of ITO is calculated in real-time as a function of the cell’s Vm, and 
injected into the cell with opposite polarity during AP recording, thus cancelling out 
defined fractions of ITO. Dynamic-clamping has previously been used to alter ventricular 
ITO or ICaL (Sun & Wang 2005; Dong et al. 2006; Dong et al. 2010; Madhvani et al. 
2011) and a stretch-activated current in rat atrial cells (Wagner et al. 2004), but not so 
far to alter ITO in atrial cells. No ion current has been studied previously using dynamic-
clamping in human atrial cells. 
 The aim, therefore, was to investigate effects of selective, graded changes in ITO on 
AP shape and APD, and on afterdepolarisations or abnormal automaticity in the 
presence of β-adrenergic-stimulation, using the dynamic-clamp technique in human and 
rabbit atrial cells. 
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Methods 
 
Ethical approval 
Procedures and experiments involving human atrial cells were approved by the West of 
Scotland Research Ethics Service (REC: 99MC002). Written, informed consent was 
obtained from all patients. Procedures and experiments involving rabbit atrial cells (UK 
Project Licence No. PPL60/40206) were approved by Glasgow University Ethics 
Review Committee. All procedures and experiments conformed to the principles of UK 
regulations, as described in Drummond (2009).  
 
Atrial cell isolation 
Cells were isolated from rabbit and human atrial tissues, as described previously 
(Workman et al. 2000; Workman et al. 2001). Rabbits (New Zealand White, male, age 
17.2±1.0 weeks, weight 3.1±0.1 kg; n=24) were humanely killed by intravenous 
injection of anaesthetic (100 mg/kg pentobarbital sodium) and removal of the heart, 
which was retrogradely perfused via the aorta for enzymatic dissociation of left atrial 
cells (Workman et al. 2000). Right atrial appendage tissues were obtained from 14 adult 
patients (59.4±2.6 years; 13 male/1 female) undergoing cardiac surgery (79%: coronary 
artery bypass graft; 21%: aortic valve replacement). All patients were in sinus rhythm 
with no history of AF. 79% had angina; 57%: hypertension; 43%: myocardial 
infarction. 21% had mild/moderate left ventricular systolic dysfunction (LVSD); 79% 
had no LVSD. Cardiac drugs: β-blocker (36%), ACE inhibitor/angiotensin receptor-
blocker (36%), Ca2+ channel blocker (29%), statin (79%), nitrate (36%), nicorandil 
(29%). Cells were isolated by the chunk technique (Workman et al. 2001), and stored 
for ≤9 hr at ~20oC in a low [Ca2+] solution containing (mM): NaCl (140), KCl (4), 
CaCl2 (0.18), MgCl2 (1), glucose (11) and HEPES (10); pH 7.4. 
 
Conventional whole-cell-patch clamp technique  
Cells were superfused at 35-37oC with the above solution except with [Ca2+] at 1.8 mM. 
Microelectrodes (1.5-5 MΩ) contained (mM): K-aspartate (130), KCl (15), NaCl (10), 
MgCl2 (1), HEPES (10), EGTA (0.1); pH 7.25. Membrane currents and APs were 
stimulated and recorded by whole-cell-patch clamp, with an AxoClamp 2B amplifier 
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(Axon Instruments) and WinWCP or WinEDR software (J Dempster). ITO was 
stimulated by voltage-clamping with the activation and inactivation protocols in Fig 
1A&C. Pulse frequency was 0.1 Hz for rabbit; 0.33 Hz for human. ITO amplitude was 
calculated as peak outward minus end-pulse current, thus avoiding the slowly-
inactivating IKur and other slowly- or non-inactivating current components that 
contribute to total outward current in human atrial cells (Christ et al. 2008). 
Extracellular Cd2+ (0.2 mM) blocked ICaL. Trains of APs were stimulated at 50-600 
beats/min by current-clamping in bridge-mode with 3-5 ms pulses, 1.2-1.5x threshold. 
Most human atrial cells required a small (0.87±0.19 pA/pF, n=18) constant 
hyperpolarising current to gain ~-80 mV resting Vm, as previously (Le Grand et al. 
1994; Bénardeau et al. 1996; Workman et al. 2001).  
 
Dynamic-clamp technique 
The dynamic-clamp technique was used in model-clamp configuration (Wilders, 2006) 
to simulate systematic changes in peak ITO conductance, in rabbit and human live atrial 
cells. ITO was modelled as a simple Hodgkin-Huxley voltage-activated current based 
upon an activating parameter, m, and an inactivating parameter, h, using the following 
equations, based on (Nygren et al. 1998). 
 
The voltage-dependence of the steady-state activation and inactivation parameters (m
∞
, 
h
∞
), activation and inactivation time constant (τm, τh) and peak ITO conductance (Gmax) 
were derived from the average peak current and steady-state activation and inactivation 
curves, measured in groups of rabbit and human atrial cells (Fig 1). 
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The dynamic-clamp was custom-built using an Analog Devices ADuC 7024 analog 
microcontroller (Analog Devices Inc. Norwood, MA), incorporating a 40 MHz ARM7 
microprocessor and 12 bit A/D and D/A converters. The ITO model, executing on the 
microcontroller, was written in C and the device controlled from a host computer via an 
RS232 interface. Vm was monitored and dynamic-clamp current output injected into the 
AxoClamp 2B stimulus current pathway at precisely timed 100 µs intervals.  
 
Statistics 
Electrophysiological data are expressed as means±SE. Continuous data were compared 
using 2-sided, 2-sample paired Student's t-tests; categorical data using a χ2-test with 
Yates’ Correction. P<0.05 was regarded as statistically significant. All statistical and 
curve fitting analyses were done using Graphpad Prism 5.00 software. 
 
 
Results 
 
Comparison of live and simulated atrial ITO characteristics 
ITO showed characteristic rapid activation and decay (Fig 1Bi for rabbit; Biii for human). 
A large non-inactivating current was present in human atrial cells, reflecting mainly IKur 
(Wang et al. 1993). Mean voltage-dependence of ITO steady-state activation (Fig 1E) 
and inactivation (F) differed between rabbit and human. ITO Gmax was 24.4 nS (0.34 
nS/pF) in rabbit, and 9.9 nS (0.12 nS/pF) in human atrial cells. The time courses of ITO 
activation and inactivation were mono-exponential, and mean τ-voltage relationships 
also differed between species (Fig 1G&H). Traces in Fig 1B&D (dashed symbols) are 
dynamic-clamp (i.e. simulated) currents injected into a simple resistor (500 MΩ)-
capacitor (33 pF) circuit (Patch-1 model cell, Axon Instruments) during voltage-clamp 
with the protocols in Fig 1A&C. ITO was modelled as a fully-inactivating current (Dong 
et al. 2006), so Biv & Div do not contain the non-inactivating, IKur component. There 
was generally good agreement between live and simulated ITO in both species for ITO 
waveform, voltage- and time-dependence curves, and curve fit values (Fig 1E-H). The 
largest difference was in the steady-state voltage-dependence of ITO inactivation in 
rabbit (Fig 1F), reflected by a 3.9 mV difference in V0.5. 
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Effects of changing ITO by dynamic-clamp on rabbit atrial cell action potentials 
Action potentials from rabbit atrial cells had prominent phase 1 repolarisation and low 
amplitude plateau (Fig 2Ai; control). Partial ITO inhibition, by dynamic-clamp 
subtraction of a small (5 or 10 nS) peak ITO conductance (Fig 2Aii) slowed phase 1, 
elevated the plateau, and moderately increased APD (Fig 2Ai). 20 nS ITO subtraction, 
reflecting ~80% ITO block, markedly slowed phase 1 and elevated the plateau, and 
prolonged APD; particularly at early-mid repolarisation (APD30-50). Late repolarisation 
(e.g., at ≥100 ms; labelled) was also prolonged by ITO subtraction, despite negligible or 
zero current at ≥100 ms. At ~full ITO block (25 nS), APs had a prolonged, “spike & 
dome” shape (Fig 2Ai). Further (supra-physiological) ITO subtraction (30 nS) produced 
no extra APD increase. Addition of ITO in this cell (downward deflections in Fig 2Aii) 
enhanced phase 1 and depressed the plateau (e.g. 20 nS addition in Ai), and moderately 
shortened APD at all levels of repolarisation. Mean data (Fig 2B) revealed a non-linear 
relationship between ITO and APD, particularly APD20-50 due to prominent plateau-
elevation by ITO subtraction. Action potential maximum upstroke velocity (Vmax) was 
unaffected by ITO change (Fig 2B). Full ITO block (24.4 nS ITO subtraction) significantly 
increased mean APD20-90, and APD-64mV (reflecting cellular effective refractory period, 
ERP (Workman et al. 2000)), and had no effect on Vmax (Fig 2C). Absolute APD 
increase was greatest at APD50 (Fig 2D), consistent with the plateau-elevation. 
Nevertheless, APD90 and APD-64mV were also increased, by ~20 ms. Relative (%) APD 
increase by ITO block was markedly greater at mid than late repolarisation (Fig 2E). 
 
Effects of changing ITO by dynamic-clamp on human atrial cell action potentials  
Human atrial cell APs were typically type 3 (low- or no-dome), with prominent phase 1 
in control (Fig 3Ai). A 50% inhibition of ITO, by 5 nS dynamic-clamp subtraction (Fig 
3Aii), slowed phase 1 and moderately elevated the plateau and prolonged late 
repolarisation; APD70-90 (Fig 3Ai). Full ITO block (10 nS) elevated the plateau further 
(Fig 3Ai), but less so than in rabbit (Fig 2Ai) and further increased APD. The APD 
increase at ≥150 ms (labelled) occurred despite negligible or zero current at that time. 
Extra ITO subtraction (15-20 nS; supra-physiological) caused additional increase in late 
repolarisation and, by contrast with rabbit (Fig 2A), little further plateau-elevation. 
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Dynamic-clamp addition of ITO accelerated phase 1, lowered the plateau and decreased 
late APD (Fig 3A). Mean APD changes indicated that within the physiological range of 
peak ITO conductance (vertical dashed line in Fig 3B), ITO subtraction lengthened APD, 
particularly APD70-90 and APD-61mV (reflecting cellular ERP (Workman et al. 2001)), 
and ITO increase had the opposite effects (Fig 3B). Vmax was unaltered by ITO change 
(Fig 3B). Fig 3C shows that full ITO block (9.9 nS subtraction) significantly increased 
APD at each repolarisation level. This was most prominent in absolute terms (Fig 3D) 
for APD70-90 and APD-61mV; relative (Fig 3E) APD increase was similar at each level. 
 
ITO reduction prolongs late repolarisation mainly by elevating action potential plateau 
Fig 4, panels Ai&ii, show that interrupting the subtraction of ITO late during phase 3 
(~APD70), i.e. when current was small or zero but APD increase by ITO reduction was 
large, caused negligible deviation in the course of subsequent repolarisation: compare 
trace F with I, and see Ai inset. This was confirmed by subtracting I from F (Fig 4Aiii) 
and indicated that any residual (non-inactivated) ITO present after APD70 contributed 
little to the APD increase over control (I-C; Fig 4Aiv) during that time. When ITO 
subtraction was interrupted at the end of phase 1 (Fig 4B), i.e. early during 
repolarisation but when the highest amplitude and a large portion of ITO had already 
occurred (current leftwards of vertical line in Bii), repolarisation rapidly deviated from 
its course of a slowed phase 1, to follow control: Fig 4Bi and inset. This was confirmed 
by the small magnitude I-C (Fig 4Biv) and indicated that the marked plateau-elevation 
and APD70 increase caused by ITO reduction (F vs C in Fig 4Bi) was not a consequence 
of the ITO reduction during phase 1. Interrupting ITO subtraction midway through the 
plateau (~APD60), i.e. at a point (vertical line in Fig 4Ci) before which ITO reduction had 
markedly elevated the plateau, caused a moderate deflection in the course of subsequent 
repolarisation. The magnitude of F-I rightwards of the vertical line in Fig 4Ciii was 
larger than in 4Aiii, indicating that a residual ITO block at ~APD60 contributed, albeit to 
a small degree, to the APD increase during subsequent repolarisation. However, the 
substantially elevated plateau and prolonged APD observed well beyond the point of 
interrupting ITO subtraction, i.e. between APD60-90 (I-C rightwards of vertical line in Fig 
4Civ) showed that the major influence of ITO to prolong APD during that time had 
occurred earlier, during the plateau and after the end of phase 1, i.e. at around APD50-60. 
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Production of spontaneous depolarisations in rabbit atrial cells: evidence for DAD 
component 
Spontaneous APs or sub-threshold transient depolarisations ≥3 mV (“cellular 
arrhythmic depolarisations”; CADs (Redpath et al. 2006)), which represent 
afterdepolarisations and/or abnormal automaticity (Redpath et al. 2006), occurred 
during 6-s pauses between AP trains, in rabbit atrial cells (Fig 5). At BCL 800 ms (used 
to investigate ITO change on APD), such post-train CAD(s) occurred in 5/12 control 
cells and in 12/12 cells exposed to the β-receptor agonist isoproterenol (ISO) or 
ISO+elevated [Ca2+]o (P<0.05). In a representative cell in which post-train CADs 
occurred with ISO (panel A), rapid stimulation (BCL 100 ms) resulted in a high number 
and frequency of these CADs. Progressive reduction in stimulation rate resulted in 
fewer post-train CADs, of lower frequency at each rate, and an increase in the time 
between the last stimulated AP and the 1st CAD (coupling interval). The lowest rate 
resulted in a sub-threshold post-train CAD. Fig 5B shows a similar coupling interval 
increase in a different cell. Mean data (Fig 5C) show a linear relationship between BCL 
and both coupling interval (panel i) and amplitude (ii) between BCL 100-400 ms, 
indicating a delayed afterdepolarisation (DAD) component to these CADs. 
 
ITO reduction potentiates β-stimulation-induced CADs in rabbit atrial cells 
Effects of dynamic-clamp subtraction of ITO on CADs, in the presence of ISO, were 
investigated in rabbit atrial cells (Fig 6). In 24 cells in which no CAD occurred in 
control (e.g. panel A, top trace), ISO produced CAD(s) within the pauses between AP 
trains in 13 cells (e.g. A, lower trace), thus significantly increasing the incidence of post-
train CADs (A, histogram). ISO also elevated the AP plateau, including that of the CAD 
(A). ISO had no effect on peak ITO: 36.3±4.8 pA/pF at +50 mV in control vs 34.7±4.3 
pA/pF in ISO (P>0.05; n=8 cells, 4 rabbits). In the cells in which ISO did not produce 
post-train CADs, ITO subtraction (10 nS; ~40% ITO block) during continued ISO 
elevated the plateau further than ISO alone, and significantly increased the incidence of 
post-train CADs (Fig 6B). Furthermore, full ITO block produced post-train CADs in half 
of cells in which partial ITO block did not. ISO also produced CADs within AP trains, 
typically stabilising as rapid, continuously and irregularly firing threshold 
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depolarisations (Fig 6C). In the 15/24 cells in which these did not occur with ISO, 
subsequent ITO reduction or block significantly increased the incidence of within-train 
CADs, again associated with marked plateau-elevation (Fig 6D). 
 
Production of EADs by ITO reduction plus β-stimulation 
Transient, small amplitude depolarisations occurred during the plateau of several APs 
under ITO subtraction plus ISO, in 1/7 cells (Fig 7) in which ISO alone did not produce 
post-train CADs but subsequent 10 nS ITO subtraction did. These plateau phase 
depolarisations occurred in 0/24 cells treated with ISO alone, appeared ~20 s after ITO 
subtraction (Fig 7Aiv), persisted during each AP train (e.g. Av-viii), and disappeared 
upon ceasing ITO subtraction (Aviii). One occurred on the plateau of a post-train CAD 
(Avii). Over the 2-min period of 10 nS ITO subtraction plus ISO, 117 APs were 
stimulated in this cell. Of those, 47 (40%) had a plateau phase depolarisation, and no 
CAD (threshold or sub-threshold) occurred between stimulated APs (that could suggest 
DADs or abnormal automaticity), identifying these depolarisations as early 
afterdepolarisations (EADs). Fig 7B shows the EADs as distinct from the AP dome. Full 
(24.4 nS) ITO subtraction caused a double EAD and a “late phase” EAD (Bii). 
 
Suppression of CADs: by interrupting ITO reduction, by adding ITO, or by β1-
antagonism 
Suppression or abolition of CADs that were caused by ISO or concurrent ITO reduction 
was demonstrated using three interventions (Fig 8). 1st: interrupting dynamic-clamp 
subtraction of ITO in the presence of ISO caused a rapid reduction in the number and 
frequency of CADs in most cells (e.g. panel A, 2nd trace pair), no further CADs with 
continued ISO, and accompanying plateau-depression (e.g. A, bottom trace pair). 2nd: 
increasing ITO (by ~40%), in cells in which ISO alone produced CADs, typically rapidly 
and continuously suppressed these CADs, accompanied by plateau-depression (e.g. B, 
bottom trace pair); significantly reducing their incidence (B, histogram). Reversibility 
was assessed in 4 cells: interrupting ITO addition caused CADs to return in each. 3rd: β1-
receptor-antagonism with atenolol abolished CADs caused by decreased ITO in the 
presence of ISO (panel C). In each of 4 cells in which ISO did not produce CADs but 
subsequent ITO subtraction did (e.g. C, top 4 trace pairs) atenolol, in the continued 
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presence of ISO and ITO reduction, abolished these CADs (e.g. C, bottom trace pair); 
significantly decreasing their incidence (Fig 8C, histogram). 
 
 
Discussion 
 The key findings are that selective ITO reduction, simulated in live atrial cells for 
the first time to our knowledge using dynamic-clamping, elevated the action potential 
plateau and prolonged late repolarisation (APD70-90) in human and rabbit, and promoted 
afterdepolarisations or abnormal automaticity under β-adrenergic-stimulation. 
 Plateau-elevation by ITO subtraction was most prominent in rabbit, and terminal 
repolarisation (APD90) was increased by ~20% in both species. It was previously 
unclear what effect ITO reduction would have on human atrial APD90, because the best 
available ITO blocker, 4-AP, inhibits IKur at ≥40-fold lower concentration than ITO (Wang 
et al. 1993), human atrial IKur is large (Wang et al. 1993; Van Wagoner et al. 1997; 
Christ et al. 2008), and selective IKur reduction affects human atrial APD90 (Wang et al. 
1993; Wettwer et al. 2004). However, IKur is notoriously difficult to separate completely 
from ITO, and we cannot exclude the possibility that our ITO model included a 
component of rapidly inactivating IKur, as reported by Christ et al. (2008). Nevertheless, 
we were able to exclude the large, slowly-inactivating IKur and other non-inactivating 
current components (Christ et al. 2008) and, therefore, use the dynamic-clamp as a 
novel intervention to improve our understanding of the contribution of ITO to human 
atrial cell APD and arrhythmia mechanisms. 
 Studies of effects of selective IKur block have shown some similarities to, and 
important differences from, the present effects of ITO block. Thus, in atrial trabeculae 
from patients in sinus rhythm, micromolar 4-AP elevated the plateau, but, by contrast 
with ITO block, here, shortened APD90; likely from secondary increase in delayed 
rectifier K+ currents (Wettwer et al. 2004). Increase in both plateau and APD90, 
however, have also been reported, in human atrial cells (Wang et al. 1993). In canine 
atrial cells, C9356, an IKur(d) blocker, increased the plateau, APD20 and APD50, but with 
negligible effect on APD90 (Fedida et al. 2003). Combined ITO/IKur block in human atrial 
cells, with millimolar 4-AP, increased both plateau and APD90, by ~30% (Workman et 
al. 2001). The novel IKur/ITO/IKACh blocker, AVE0118, had negligible effect on APD90 
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(Wettwer et al. 2004; Schotten et al. 2007; Christ et al. 2008), but elevated the plateau 
(Wettwer et al. 2004; Schotten et al. 2007; Christ et al. 2008) and increased systolic 
[Ca2+]i and contractility (Schotten et al. 2007). Furthermore, Schotten et al (2007) 
showed, using various AP-clamping techniques, that such change in the AP shape was 
responsible for this drug’s positive inotropic action. Thus, in the absence of AVE0118, 
atrial cell fractional shortening was markedly increased either by elevating the plateau 
amplitude or by prolonging its duration (without changing APD90), or indeed by 
imposing the AP waveform recorded under AVE0118.  
 Previous dynamic-clamp studies of ITO used ventricular cells, from dog or guinea-
pig. In epicardial cells, which have a moderate phase 1 “notch” due to ITO, an ITO 
subtraction sufficient to eliminate this notch did not affect subsequent repolarisation 
(Sun & Wang 2005). In endocardial cells, which had small or no ITO or notch, ITO 
addition sufficient to produce a notch also lacked effect on repolarisation (Dong et al. 
2006; Dong et al. 2010). However, ventricular AP shape, some ion currents, and 
[Ca2+]i-handling differ markedly from atrial, including in human (Grandi et al. 2011), 
and the relatively large atrial ITO and phase 1 in human (Grandi et al. 2011) and rabbit 
(Giles & Imaizumi 1988) likely account for the observed relatively strong atrial APD-
response to ITO decrease. 
 The magnitude of the human atrial APD90 increase with ITO subtraction (i.e. 9% 
with 50% ITO subtraction) and block (17% with 100% ITO subtraction) is consistent with 
several mathematical models. Thus, in the Grandi model (Grandi et al. 2011), 50 and 
100% ITO decrease lengthened APD90, by 9 and 19%, respectively. In the Nygren model 
(Nygren et al. 1998), 90% ITO decrease also lengthened APD90, by 18%. By contrast, in 
the Courtemanche model (CRN) (Courtemanche et al. 1998), 50 or 90% ITO decrease 
shortened APD90. Another study, based on CRN, also reported APD90-shortening 
(Zhang et al. 2005). However, CRN generates a type 1 (spike & dome) AP, whereas the 
present APs and those generated by the other models (Nygren et al. 1998; Grandi et al. 
2011) are type 3. Moreover, modification of CRN to generate type 3s (Marshall et al. 
2012) reversed the effect of ITO decrease: a 41% decrease lengthened APD90 by 9% 
(Marshall et al. 2012); again consistent with present data. 
 The increased APD90 and APD-61mV by ITO reduction has implications for atrial 
reentry. APD
-61mV estimates cellular ERP, because -61 mV is the mean Vm from which 
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partially refractory APs took off in human atrial cells (Workman et al. 2001). Since 
leading circle reentry wavelength (λ)=ERP×conduction velocity (θ), then increased 
APD
-61mV, with the unchanged Vmax (a determinant of θ), has the potential to increase λ 
and thus inhibit reentry (Workman et al. 2011). Furthermore, ITO reduction may 
terminate spiral wave reentry, by plateau-elevation alone, according to a CRN-based 
mathematical model of human atrial 2-dimensional reentry (Pandit et al. 2005). Atrial 
electrophysiological remodelling in chronic AF and predisposing pathologies such as 
atrial dilation and LVSD invariably involves ITO reduction (Le Grand et al. 1994; Van 
Wagoner et al. 1997; Christ et al. 2008; Workman et al. 2009; Nattel et al. 2007; 
Workman et al. 2008; Schotten et al. 2011; Dobrev et al. 2012). However, several other 
currents remodel also, which likely have more bearing on atrial ERP than ITO, despite 
secondary ionic effects of ITO reduction; making the consequences of ITO reduction 
difficult to predict. For example, increased inward rectifier K+ current (IK1 & IKACh) and 
altered [Ca2+]i-handling are likely the principle mechanisms of ERP-shortening in 
chronic AF (Dobrev et al. 2005; Cha et al. 2006; Workman et al. 2008; Voigt et al. 
2012; Dobrev et al. 2012). Human atrial ERP increase, by chronic β-blockade 
(Workman et al. 2003), was associated with decreased ITO and IK1 (Marshall et al. 
2012), and mathematical modelling suggested a small contribution from ITO (Marshall 
et al. 2012). It is conceivable that ERP increase by some other drugs used to treat AF, 
e.g. flecainide, propafenone and amiodarone, could also involve their observed 
inhibition of ITO (Wang et al. 1995; Gross & Castle 1998; Varro A et al. 1996), in 
addition to their recognised effects on other ion currents and [Ca2+]i-handling (Dobrev 
et al. 2012). Since only ITO decrease was detected in patients with LVSD, associated 
with atrial ERP-shortening (Workman et al. 2009), the present data indicate that other, 
as yet unidentified, ionic mechanisms were responsible for the ERP-shortening in that 
study (Workman et al. 2009). 
 Critically timed interruption of ITO subtraction during human atrial repolarisation 
revealed that the present APD90-prolongation was not caused by ITO reduction during 
phase 1, nor by reduction of any substantial residual ITO flowing during late 
repolarisation (APD70 or beyond), but rather by the effect of ITO reduction between these 
points, i.e. mid plateau (APD50-60), to elevate the plateau. The mid plateau-to-APD90 
region is substantially maintained by forward mode (depolarising) INa/Ca from Ca2+ 
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extrusion after CICR: INa/Ca block with Li+ ~halved APD-60mV (Bénardeau et al. 1996). 
In mouse ventricular cells, which also have type 3 APs, genetic ITO reduction slowed 
ICaL inactivation and increased net Ca2+ influx via ICaL, and markedly increased systolic 
[Ca2+]i (Sah et al. 2002). The increased net ICaL in that study likely contributed 
substantially to the increased [Ca2+]i, but increased reverse-mode INa/Ca (Ca2+ influx) 
may also contribute, since plateau-elevation may shift Vm towards ENa/Ca (Sah et al. 
2003). Indeed, support for such a contribution from reverse-mode INa/Ca was provided by 
the AP-clamp studies in canine atrial cells from Schotten et al (2007). They showed 
that, in control cells, imposing the AP waveform recorded under AVE0118 (a drug 
which markedly elevated the plateau by inhibiting IKur and ITO, and increased systolic 
[Ca2+]i and contractility) had negligible effect on net Ca2+ influx via ICaL despite also 
increasing contractility, yet inhibition of reverse-mode INa/Ca (using KBR7943 or 
elimination of pipette Na+) abolished this AP-clamp-induced positive inotropic effect 
(Schotten et al. 2007). Irrespective of the mechanism of systolic [Ca2+]i increase 
resulting from selective reduction in ITO, a consequent increase in depolarising INa/Ca is a 
likely contributory mechanism for the effect of ITO decrease to prolong APD90 in the 
present study. Furthermore, INa/Ca is the major current responsible for DADs and 
abnormal automaticity, especially during adrenergic-stimulation, which increases ICaL 
amplitude, sarcoplasmic reticular Ca2+ content, and thus systolic [Ca2+]i (Workman, 
2010). 
 Afterdepolarisations (DADs and EADs) and abnormal automaticity have complex, 
partially shared mechanisms of generation and are difficult to distinguish, hence their 
grouping here as CADs (Redpath et al. 2006). We found a DAD component in rabbit 
atrial cells under β-stimulation, since post-train CADs showed a rate-dependence of 
coupling interval and amplitude characteristic of DADs (Johnson et al. 1986). 
Nevertheless, ISO produced a variety of spontaneous activities, during and after trains, 
so we did not restrict investigation of ITO change to DADs. ISO was used at Emax 
concentration for ICaL (Redpath et al. 2006), and had no effect on ITO. When ISO alone 
did not produce CADs, it nevertheless elevated the plateau. Subsequent ITO subtraction 
produced immediate (within 1 beat) further plateau-elevation, and CADs followed 
either within a few beats or after several AP trains; their incidence increasing with 
strength of ITO subtraction. It is reasonable to suppose that these CADs resulted from the 
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marked plateau-elevation from concurrent ITO subtraction and β-stimulation, each of 
which increases [Ca2+]i (Sah et al. 2002; Dong et al. 2010; Workman, 2010), with 
consequent [Ca2+]i-loading sufficient to produce DADs and/or abnormal automaticity 
via spontaneous sarcoplasmic reticular Ca2+ release and subsequent inward INa/Ca. 
Furthermore, in one cell, ISO plus ITO subtraction produced EADs, distinguished by 
their consistent, regular appearance during phase 2, with no DADs or abnormal 
automaticity. The Vm from which they arose (-25 to -15 mV) centred on “window ICaL” 
(where ICaL activation and inactivation curves overlap; -30 to -10 mV in rabbit atrium 
(Lindblad et al. 1996)), consistent with a recognised mechanism of EAD generation: 
APD increase at window ICaL voltages. The contribution of window ICaL to EADs was 
studied by dynamic-clamping ICaL in rabbit ventricular cells (Madhvani et al. 2011). 
EAD formation was modified by only small changes in ICaL voltage-dependence that did 
not change [Ca2+]i (Madhvani et al. 2011). However, effects of ITO change on window 
ICaL remain to be studied. Atrial DADs and/or EADs occur in several animal models of 
congestive heart failure (CHF)-induced AF (Nattel et al. 2007; Schotten et al. 2011; 
Dobrev et al. 2012). Since these models also feature decreased atrial ITO and increased 
APD and/or INa/Ca (Nattel et al. 2007; Schotten et al. 2011; Dobrev et al. 2012), it is 
conceivable that ITO decrease may contribute to atrial afterdepolarisation formation in 
CHF. CADs were suppressed, in the present study, by removal of ITO subtraction, or by 
dynamic-clamp addition of ITO. The associated AP (or CAD) plateau-depression in each 
case is consistent with suppression of CADs by opposition of [Ca2+]i-loading. CADs 
were also suppressed by atenolol, used here at therapeutic concentration, 1 µM (de 
Abreu et al. 2003), likely involving antagonism of [Ca2+]i-loading produced by β-
stimulation of ICaL and CICR (Workman, 2010). 
 Study limitations: 1) We did not study cells from patients with AF, and since 
chronic AF remodels atrial ion currents and [Ca2+]i-handling (Schotten et al. 2011; 
Dobrev et al. 2012), it may be expected to alter APD responses to ITO change; as shown 
for some other currents. For example, block of IKur (Wettwer et al. 2004) or 
IKur/ITO/IKACh (Wettwer et al. 2004; Christ et al. 2008) increased APD90 in atrial 
trabeculae from patients with chronic AF, but not sinus rhythm. Chronic AF also 
increased the propensity for atrial DADs, by increasing diastolic sarcoplasmic reticular 
Ca2+ leak and INa/Ca (Voigt et al. 2012), and so could also alter effects of ITO change on 
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DADs. Whether chronic AF could affect the propensity to EADs, and hence their 
response to ITO change, is unclear. 2) Whilst the modelled ITO generally conformed well 
to the live data, with a maximum V0.5 discrepancy of <4 mV, an influence of such a 
difference on the dynamic-clamped AP cannot be excluded. 3) Rabbit and human atrial 
ITO is carried by different pore-forming α-subunits: Kv1.4 and Kv4.3, respectively 
(Wang Z et al. 1999), which confer markedly different reactivation kinetics and rate-
dependence of ITO between these species. At the stimulation rate (75 beats/min) and 
temperature (35-37oC) used for all the dynamic-clamp experiments, human atrial ITO 
would reactivate fully between beats, whereas rabbit atrial ITO would be ~50% 
reactivated (Fermini et al. 1992) due to its relatively slow reactivation kinetics. We did 
not model this slow reactivation, and our rabbit atrial ITO model therefore incorporated 
more “human-like” reactivation kinetics than occur in-vivo. Nevertheless, a subtraction 
of ~40% of the fully reactivated ITO significantly increased the incidence of 
afterdepolarisations in the rabbit atrial cells. 4) The holding current required in human 
(not rabbit) atrial cells to gain ~-80 mV resting Vm, although kept constant in each cell 
and independent of dynamic-clamp current, is nevertheless recognised to shorten APD 
and depress the plateau. Such effects could lead to an underestimation of the potential 
for ITO reduction to produce arrhythmogenic activity in human atrial cells in-vivo, but an 
overestimation of the potential for ITO addition to prevent such activity. 5) Whole-cell-
patch clamp uses fixed intracellular and extracellular solutions, and the isolated cells 
also lack electrotonic influence from other cells. 6) The dynamic-clamp was used here 
to mimic the electrical effects of ITO reduction. However, it is recognised that this 
technique cannot mimic local [K+] changes (Wilders, 2006). 
 In conclusion, changes in atrial cell action potential shape and durations from 
selective ITO modulation, shown here for the first time using dynamic-clamp, have the 
potential to influence reentrant and non-reentrant arrhythmia mechanisms, with 
implications for both the development and treatment of AF. 
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Figure legends 
 
Figure 1: Comparison between live and simulated atrial ITO in rabbit and human. 
Empty symbols: rabbit data; filled symbols: human. Solid lines: live atrial cell data; 
dashed lines: current generated by dynamic-clamp ITO models. Steady-state voltage-
dependence: ITO activation, using voltage-clamp protocol A, resulting in currents Bi-iv; 
ITO inactivation with protocol C, resulting in currents Di-iv. E-H: voltage-dependence of 
ITO activation and inactivation in live atrial cells (n=8-15, 5-6 rabbits; 10-12 cells, 6-7 
patients) or from single simulation runs. ITO steady-state activation (E) and inactivation 
(F) curves constructed by dividing peak ITO at each voltage by driving force to give 
conductance, G, and dividing G by G
max
. ITO activation (G) and inactivation (H): time 
constants estimated from exponential functions fitted to activation and inactivation time 
courses; half activation and inactivation potentials, V0.5, and slopes, minimum and 
maximum time constants, τ
min & τmax, estimated by fitting Boltzmann functions; values 
shown with corresponding curve labels.  
 
Figure 2: Effects of decreasing and increasing ITO conductance by dynamic-clamp 
on rabbit atrial cell APs. A. Superimposed action potentials, AP (i) and corresponding 
dynamic-clamp (D-C) currents (ii) recorded from a single representative atrial cell, 
without D-C (Control), or with D-C subtraction or addition of ITO over a range of peak 
conductances (labelled). D-C subtracted ITO is +ve, because +ve charge is injected into 
cell to compensate for the loss of +ve charge via native ITO. Stimulation rate=75 
beats/min to permit sufficient time for ITO reactivation (Workman et al. 2000; Giles & 
Imaizumi 1988). P=current pulse (3 ms, ~1.2x threshold) to stimulate APs. B. 
Relationship between ITO conductance (-ve ∆ peak ITO=D-C subtraction of ITO) and 
APD20-90, APD-64mV and Vmax; n=16 cells, 6 rabbits. Vertical arrow indicates 24.4 nS ITO 
subtraction, reflecting full ITO block. Effect of full ITO block on APDs and Vmax shown 
by (C) comparing control (empty bars) with 24.4 nS ITO subtraction (filled; * =P<0.05 
vs control, NS=not significant), or as absolute (D) or relative (E) APD change.  
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Figure 3: Effects of decreasing and increasing ITO by dynamic-clamp on human 
atrial cell APs. A. Superimposed APs (i) and corresponding D-C currents (ii) recorded 
from a single representative human atrial cell, without D-C (Control), or with D-C 
subtraction (sub) or addition of ITO over a range of peak conductances. Rate=75 
beats/min. P=current pulse (5 ms, ~1.5x threshold) to stimulate APs. B. Relationship 
between ITO conductance and APDs and Vmax; n=18 cells, 6 patients. Vertical dashed 
arrow indicates 9.9 nS ITO subtraction, reflecting full ITO block. Effects of full ITO block 
shown by (C) comparing control (empty bars) with 9.9 nS ITO subtraction (filled; 
*=P<0.05 vs control), or as absolute (D) or relative (E) APD change.  
 
Figure 4: ITO reduction prolongs late repolarisation mainly by elevating AP 
plateau. Effect on human atrial AP late repolarisation of interrupting D-C subtraction of 
ITO (by temporarily switching off D-C current injection) during (A) late repolarisation 
(AP phase 3), (B) early repolarisation (phase 1), and (C) mid repolarisation (phase 2), in 
a single cell. Rate=75 beats/min. Top panels (i) show superimposed, representative APs 
recorded without D-C subtraction of ITO (control: C), or with 9.9 nS ITO subtraction for 
the full (F) duration of the AP, or with D-C subtraction of ITO interrupted (I) at the point 
indicated by vertical dashed lines. Insets show magnified portion of APs close to point 
of interruption. Panels ii show corresponding superimposed D-C subtraction currents. 
Inset of B: example of non-superimposed D-C-interrupted* trace. Panels iii&iv: 
subtraction of AP trace I from F, and C from I (as in corresponding top panels).  
 
Figure 5: Production of spontaneous depolarisations in rabbit atrial cells: evidence 
for DAD component. A. APs (upper trace) recorded from a rabbit atrial cell during 
stimulation with trains of current pulses (lower trace) delivered at BCL shown, in the 
presence of isoproterenol (ISO) 0.1 µM. *=sub-threshold CAD. B. APs in a different 
cell at magnified timescale at short BCLs using same protocol as (A). C. BCL vs mean 
(±SE) coupling interval (i) and amplitude (ii) of post-train AP or CAD with 0.1 µM ISO 
or 0.1 µM ISO+3.6 mM [Ca2+]. n=10-12 cells, 5 rabbits.  
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Figure 6: ITO reduction potentiates β-stimulation-induced CADs in rabbit atrial 
cells. Effects of ISO 0.1 µM +/- D-C subtraction of ITO on the incidence of CADs. 
Upper traces of trace pairs=AP trains (75 beats/min) followed by 2-s pauses. Lower 
traces=corresponding currents: AP stimulus pulses +/- D-C reduction of ITO (of labelled 
conductance & duration). Histograms=incidences of CADs following (post-train) or 
during (within-train) AP trains; values within bars=cell n (≤7 rabbits), *=P<0.05. A. 
Effect of ISO 1.5 min (max. time needed for stable effect on APs & CADs) on post-train 
CADs, without D-C subtraction of ITO. B. In the cells in which ISO did not produce 
CADs in (A), effects of 10 nS ITO subtraction (3
rd
 trace pair) and/or 24.4 nS ITO 
subtraction (histogram) on post-train CADs. C&D: corresponding changes to within-
train CADs.  
 
Figure 7: Production of EADs by ITO reduction plus β-stimulation. A. Upper traces 
of trace pairs=AP trains (75 beats/min) followed by 2-s pauses; lower 
traces=corresponding currents, recorded in a rabbit atrial cell before (i) and after (ii) 
ISO 0.1 µM and during subsequent D-C subtraction of ITO (iii-viii). •=EAD. S=sub-
threshold CAD. T=threshold CAD. B. Expanded portions of panel A traces: i, 4th, 5th & 
6th APs from (Aiv); ii, 1st, 2nd & 3rd APs from (Avii).  
 
Figure 8: Suppression of CADs: by interrupting ITO reduction, by adding ITO, or by 
β1-antagonism. Upper traces of trace pairs=AP trains (75 beats/min) followed by 2-s 
pauses; lower traces=corresponding currents, recorded in rabbit atrial cells. 
Histograms=incidences of CADs (combined post- and within-train); values within 
bars=cell n, *=P<0.05. A. Effect of interrupting D-C subtraction of ITO on CADs in cells 
(3 rabbits) in which ISO did not produce CADs but concurrent D-C subtraction of ITO 
(10 or 24.4 nS) did. B. Effect of D-C addition of ITO on CADs in cells (4 rabbits) in 
which ISO produced CADs. C. Effect of atenolol (1 µM) on CADs in cells (3 rabbits) in 
which ISO did not produce CADs but concurrent D-C subtraction of ITO did.  
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Figure 1: Comparison between live and simulated atrial ITO in rabbit and human. Empty symbols: rabbit data; filled 
symbols: human. Solid lines: live atrial cell data; dashed lines: current generated by dynamic-clamp ITO models. Steady-
state voltage-dependence: ITO activation, using voltage-clamp protocol A, resulting in currents Bi-iv; ITO inactivation with 
protocol C, resulting in currents Di-iv. E-H: voltage-dependence of ITO activation and  inactivation in live atrial cells (n=8-
15, 5-6 rabbits; 10-12 cells, 6-7 patients) or from single simulation runs. ITO steady-state activation (E) and  inactivation 
(F) curves constructed by dividing peak ITO at each voltage by driving force to give conductance, G, and dividing G by 
Gmax. ITO activation (G) and  inactivation (H): time constants estimated from exponential functions fitted to activation and 
inactivation time courses; half activation and  inactivation potentials, V0.5, and slopes, minimum and maximum time 
constants, τmin & τmax, estimated by fitting Boltzmann functions; values shown with corresponding curve labels.
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Figure 2: Effects of decreasing and increasing ITO conductance by dynamic-clamp on rabbit atrial cell APs.
A. Superimposed action potentials, AP (i) and corresponding dynamic-clamp (D-C) currents (ii) recorded from a 
single representative atrial cell, without D-C (Control), or with D-C subtraction or  addition of ITO over a range of 
peak conductances (labelled). D-C subtracted ITO is +ve, because +ve charge is injected into cell to compensate for 
the loss of +ve charge via native ITO. Stimulation rate=75 beats/min to permit sufficient time for ITO reactivation 
(Workman et al. 2000; Giles & Imaizumi 1988). P=current pulse (3 ms, ~1.2x threshold) to stimulate APs. B. 
Relationship between ITO conductance (-ve ∆ peak ITO=D-C subtraction of ITO) and APD20-90, APD-64mV and Vmax; 
n=16 cells, 6 rabbits. Vertical arrow indicates 24.4 nS ITO subtraction, reflecting full ITO block. Effect of full ITO block 
on APDs and Vmax shown by (C) comparing control (empty bars) with 24.4 nS ITO subtraction (filled; *=P<0.05 vs
control, NS=not significant), or as absolute (D) or relative (E) APD change.
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Figure 3: Effects of decreasing and increasing ITO by dynamic-clamp on human atrial cell APs.
A. Superimposed APs (i) and corresponding D-C currents (ii) recorded from a single representative human atrial cell, 
without D-C (Control), or with D-C subtraction (sub) or  addition of ITO over a range of peak conductances. Rate=75 
beats/min. P=current pulse (5 ms, ~1.5x threshold) to stimulate APs. B. Relationship between ITO conductance and 
APDs and Vmax; n=18 cells, 6 patients. Vertical dashed arrow indicates 9.9 nS ITO subtraction, reflecting full ITO block. 
Effects of full ITO block shown by (C) comparing control (empty bars) with 9.9 nS ITO subtraction (filled; *=P<0.05 vs
control), or as absolute (D) or relative (E) APD change.
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Figure 4: ITO reduction prolongs late repolarisation mainly by elevating AP plateau.
Effect on human atrial AP late repolarisation of interrupting D-C subtraction of ITO (by temporarily switching off D-C current 
injection) during (A) late repolarisation (AP phase 3), (B) early repolarisation (phase 1), and (C) mid repolarisation (phase 2), 
in a single cell. Rate=75 beats/min. Top panels (i) show superimposed, representative APs recorded without D-C subtraction 
of ITO (control: C), or with 9.9 nS ITO subtraction for the full (F) duration of the AP, or with D-C subtraction of ITO interrupted (I) 
at the point indicated by vertical dashed lines. Insets show magnified portion of APs close to point of interruption. Panels ii
show corresponding superimposed D-C subtraction currents. Inset of B: example of non-superimposed D-C-interrupted* 
trace. Panels iii&iv: subtraction of AP trace I from F, and C from I (as in corresponding top panels).
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Figure 5: Production of spontaneous depolarisations in rabbit atrial cells: evidence for DAD component.
A. APs (upper trace) recorded from a rabbit atrial cell during stimulation with trains of current pulses (lower trace) 
delivered at BCL shown, in the presence of isoproterenol (ISO) 0.1 µM. *=sub-threshold CAD. B. APs in a different cell 
at magnified timescale at short BCLs using same protocol as (A). C. BCL vs mean (±SE) coupling interval (i) and 
amplitude (ii) of post-train AP or CAD with 0.1 µM ISO or 0.1 µM ISO+3.6 mM [Ca2+]. n=10-12 cells, 5 rabbits. 
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Figure 6: ITO reduction potentiates β-stimulation-induced CADs in rabbit atrial cells.
Effects of ISO 0.1 µM +/- D-C subtraction of ITO on the incidence of CADs. Upper traces of trace pairs=AP trains (75 
beats/min) followed by 2-s pauses. Lower traces=corresponding currents: AP stimulus pulses +/- D-C reduction of ITO
(of labelled conductance & duration). Histograms=incidences of CADs following (post-train) or during (within-train) AP 
trains; values within bars=cell n (≤7 rabbits), *=P<0.05. A. Effect of ISO 1.5 min (max. time needed for stable effect on 
APs & CADs) on post-train CADs, without D-C subtraction of ITO. B. In the cells in which ISO did not produce CADs in 
(A), effects of 10 nS ITO subtraction (3rd trace pair) and/or 24.4 nS ITO subtraction (histogram) on post-train CADs. C&D: 
corresponding changes to within-train CADs. 
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Figure 7: Production of EADs by ITO reduction plus β-stimulation.
A. Upper traces of trace pairs=AP trains (75 beats/min) followed by 2-s pauses; lower traces=corresponding 
currents, recorded in a rabbit atrial cell before (i) and after (ii) ISO 0.1 µM and during subsequent D-C 
subtraction of ITO (iii-viii). •=EAD. S=sub-threshold CAD. T=threshold CAD. B. Expanded portions of panel A
traces: i, 4th, 5th & 6th APs from (Aiv); ii, 1st, 2nd & 3rd APs from (Avii). 
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Figure 8: Suppression of CADs: by interrupting 
ITO reduction, by adding ITO, or by β1-antagonism.
Upper traces of trace pairs=AP trains (75 beats/min) 
followed by 2-s pauses; lower traces=corresponding 
currents, recorded in rabbit atrial cells. Histograms= 
incidences of CADs (combined post- and within-
train); values within bars=cell n, *=P<0.05. A. Effect 
of interrupting D-C subtraction of ITO on CADs in 
cells (3 rabbits) in which ISO did not produce CADs 
but concurrent D-C subtraction of ITO (10 or 24.4 nS) 
did. B. Effect of D-C addition of ITO on CADs in cells 
(4 rabbits) in which ISO produced CADs. C. Effect 
of atenolol (1 µM) on CADs in cells (3 rabbits) in 
which ISO did not produce CADs but concurrent D-
C subtraction of ITO did. 
